Glucose Control in Pre-Diabetic Renal Transplant Patients: Efficacy and Safety of Vildagliptin and Pioglitazone.

Trial Profile

Glucose Control in Pre-Diabetic Renal Transplant Patients: Efficacy and Safety of Vildagliptin and Pioglitazone.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Apr 2013

At a glance

  • Drugs Pioglitazone (Primary) ; Vildagliptin (Primary)
  • Indications Diabetes mellitus; Glucose intolerance
  • Focus Therapeutic Use
  • Acronyms GCPD
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 13 Apr 2013 Planned number of patients changed from 48 to 114 as reported by European Clinical Trials Database record.
    • 02 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top